« Previous
Next »
The Knee
Volume 16, Issue 6
, Pages 466-472
, December 2009
Changes of gait patterns and muscle activity after intraarticular treatment of patients with osteoarthritis of the knee: A prospective, randomised, doubleblind study
References
- . An update on the epidemiology of knee and hip osteoarthritis with a view to prevention. Arthritis Rheum. 1998;41(8):1343–1355
- . Beyond disability: measuring the social and personal consequences of osteoarthritis. Osteoarthr Cartil. 1999;7(2):230–238
- A prospective, randomised, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthr Cartil. 2002;10(7):518–527
- Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomised, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48(2):370–377
- . A randomised, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol. 2004;31(2):333–343
- . Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil. 1995;3(4):269–273
- . Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis. 1985;44(12):817–822
- . A new approach to the treatment of osteoarthritis: viscosupplementation. Osteoarthr Cartil. 1993;1(2):85–87
- . Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomised clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25(11):2203–2212
- . High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil. 1993;1(2):97–103
- . A prospective, randomised, double-blind, placebo controlled study to evaluate the efficacy of intraarticular hyaluronic acid for osteoarthritis of the knee. J Rheumatol. 2006;33(5):951–956
- A prospective, randomised, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthr Cart. 2002;10(7):506–517
- . Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled study. Clin Exp Rheumatol. 2001;19(3):265–270
- . Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee. J Knee Surg. 2006;19(1):19–27
- . A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee. 2003;10(3):291–293
- . Efficacy of Hylan G.-F., 20 and sodium hyaluronate in the treatment of osteoarthritis of the knee — a prospective randomised clinical trial. Knee. 2008;15(4):318–324
- . Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis—a prospective clinical trial. Osteoarthr Cartil. 2002;10(9):680–686
- . Changes in sagittal ground reaction forces after intra-articular hyaluronate injections for knee osteoarthritis. Arch Phys Med Rehabil. 2004;85(6):951–955
- . Effects of intra-articular hylan G-F 20 injections on clinical and biomechanical characteristics of the knee in osteoarthritis. Int J Rehabil Res. 2005;28(4):371–374
- . Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494–502
- . Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;(248):13–14
- . Indexes of severity for osteoarthritis of the hip and knee. Validation—value in comparison with other assessment tests. Scand J Rheumatol Suppl. 1987;65:85–89
- . Measurement of pain. Lancet. 1974;2(7889):1127–1131
- European recommendations for surface electromyography. Results of the SENIAM project.: Roessingh Research and Development bv. 1999;
- . German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment. Soc Sci Med. 1995;41(10):1359–1366
- . Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthr Cartil. 2004;12(8):642–649
- . A double-blind randomised controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthr Cartil. 2005;
- . Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil. 2005;84(4):278–283quiz 284, 293
- . Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ. 2005;172(8):1039–1043
- . Improvement of muscle strength in osteoarthritic knee patients after intraarticular knee injection of hyaluronan. Am J Phys Med Rehabil. 2005;84(4):274–277
- . Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomised, double-blind, parallel-design multicentre study. Rheumatology (Oxford). 2002;41(11):1240–1248
- . Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomised trial. J Bone Joint Surg Am. 2003;85-A(7):1197–1203
- . Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum. 1994;37(4):521–528
PII: S0968-0160(09)00046-5
doi: 10.1016/j.knee.2009.03.003
© 2009 Elsevier B.V. All rights reserved.
« Previous
Next »
The Knee
Volume 16, Issue 6
, Pages 466-472
, December 2009
